Table 1.
Demographic and clinical data of the study population.
| Variable | |
|---|---|
| N | 1,644 |
| Demographic Characteristics | |
| Gender, female, n (%) | 917 (55.8) |
| Age, years | 30.1 ± 12.0 |
| Age of diagnosis, years | 14.6 ± 8.9 |
| Duration of diabetes, years | 15.3 ± 9.3 |
| Years of formal education, years | 12.3 ± 3.8 |
| Economic status, n (%) | |
| High | 49 (3.0) |
| Middle | 745 (45.3) |
| Low | 795 (48.4) |
| Very low | 55 (3.3) |
| Insulin regimens, n (%) | |
| Intermediate or long acting | 80 (4.9) |
| Intermediate/long plus short acting | 1.510 (91.8) |
| CSII | 54 (3.3) |
| Clinical Data | |
| HbA1c (%) | 9.0 ± 2.1 |
| HbA1c, mean (SD), mmol/mol | 74.5 ± 23.1 |
| Use of angiotensin-converting enzyme (ACE) inhibitor, yes, n (%) | 356 (20.2) |
| Use of Statin, yes n (%) | 382 (21.7) |
| BMI, mean (SD), kg/m2 | 24.2 ± 4.2 |
| Arterial hypertension, yes, n (%) | 288 (17.5) |
| Macrovascular disease, yes n (%) | 57 (3.5) |
| Current smoker, yes, n (%) | 86 (5.6) |
| Chronic kidney disease, yes, n (%) | 404 (24.6) |
| Diabetic retinopathy, yes, n (%) | 589 (35.8) |
Data are presented as numbers (percentages) or means ± SD (standard deviation).
BMI, body mass index; HbA1c, glycated hemoglobin; LDL-c, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol; CSII, Continuous Subcutaneos Insulin Infusion.